ClinicalTrials.Veeva

Menu

PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery

Baxter logo

Baxter

Status

Completed

Conditions

Adhesion

Treatments

Device: ADEPT

Study type

Observational

Funder types

Industry

Identifiers

NCT05811585
BXU562080

Details and patient eligibility

About

Postoperative adhesions develop in most patients after gynecologic surgery, likely resulting in significant morbidity, complications, and considerable increases in healthcare costs. Good surgical techniques, including a minimally invasive approach, may reduce adhesions and minimize the abovementioned complications. The agents for prevention or reduction of adhesion formation are placed inside the abdominal cavity, and especially in the pelvic cavity, which contains the female reproductive organs. ADEPT Adhesion Reduction Solution, hereinafter referred to as ADEPT, is intended for use as an intraperitoneal instillate for the reduction of adhesions following gynecological laparoscopic surgeries. The objective of this study is to evaluate the effectiveness and safety of ADEPT by detecting the incidence of adhesion-related morbidities (adhesion-related readmissions, including reoperations) after laparoscopic gynecologic surgery through a single-arm, retrospective, chart review with a patient questionnaire intended to supplement the patient chart.

Enrollment

153 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult female patients who, at the time of surgery, were ≥ 18 years of age and who had undergone an index laparoscopic gynecologic surgery at least 2 years prior to the start of the study.
  • Patients in whom ADEPT® was used as an irrigant during the index laparoscopic gynecologic surgical procedure and as an intraperitoneal instillate for the reduction of adhesions following laparoscopic surgery.

Exclusion criteria

  • Patients who had frank infection in the abdominopelvic cavity at the time of the surgery.
  • Patients who were pregnant or nursing at the time of the surgery.

Trial design

153 participants in 1 patient group

Patient of a Laparoscopic Gynecologic Surgery
Description:
ADEPT administered intraperitoneally as a liquid, used for irrigation throughout the procedure and for final instillation of a suitable amount at the end of the procedure.
Treatment:
Device: ADEPT

Trial contacts and locations

2

Loading...

Central trial contact

Baxter Clinical Trials Disclosure Call Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems